Form 4: P10, Inc. Executives and Trusts Receive Stock Options and Restricted Stock Units

Sentiment:

SEC Form 4


Multiple executives and trusts associated with P10, Inc. received grants of restricted stock units and stock options on February 14, 2025, according to a Form 4 filing.

Summary

  • A Form 4 filing reveals that several executives and trusts related to P10, Inc. received grants of restricted stock units (RSUs) and stock options on February 14, 2025.
  • The recipients include Nell M. Blatherwick, Andrew R. Nelson, the Charles K. Huebner Trust, the Thomas P. Danis Revocable Living Trust, the Jon I. Madorsky Revocable Trust, Alexander I. Abell, and David M. McCoy.
  • The RSUs vest one year from the grant date, contingent upon continuous employment.
  • The stock options, with an exercise price of $12.61, vest 25% annually over four years from the grant date, also subject to continuous employment and potential accelerated vesting upon certain events.
  • The filing indicates that the Reporting Persons may be deemed to be members of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's Common Stock, but each disclaims beneficial ownership of securities held by other Reporting Persons.

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices, which are generally viewed positively as they align management interests with shareholder value. The sentiment is neutral to slightly positive.

Positives

  • The grants of RSUs and stock options align the interests of the executives and trustees with the long-term performance of P10, Inc.
  • The vesting schedules incentivize continued employment and contribution to the company's success.

Risks

  • The vesting of RSUs and stock options is contingent upon continued employment, creating a potential risk of loss of key personnel if employment is terminated.
  • The value of the stock options is dependent on the future stock price of P10, Inc., which is subject to market fluctuations and company performance.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance, but the grants of equity-based compensation suggest an expectation of continued growth and value creation.

Management Comments

  • The Reporting Persons disclaim beneficial ownership of the securities of the Issuer held by each other Reporting Person, and the filing of this Form 4 shall not be construed as an admission that the Reporting Persons are beneficial owners of the securities of the Issuer reported herein.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The grants of RSUs and stock options are a common method of compensating executives and aligning their interests with those of shareholders.

Comparison to Industry Standards

  • Equity compensation practices vary across the asset management industry, but grants of RSUs and stock options are common.
  • Companies like Blackstone (BX), Apollo Global Management (APO), and KKR & Co. (KKR) also utilize equity-based compensation to incentivize their employees.
  • The vesting schedules and terms of the grants are generally in line with industry standards.

Stakeholder Impact

  • Shareholders may view the grants of RSUs and stock options positively, as they incentivize management to improve company performance.
  • Employees receiving the grants are likely to be motivated by the potential for future gains.

Key Dates

DateDescription
2003-03-10Date of Thomas P. Danis, Jr. Revocable Living Trust
2008-12-01Date of Jon I. Madorsky Revocable Trust
2025-02-14Date of transaction: Grant of restricted stock units and stock options
2026-02-14Vesting date for restricted stock units
2036-02-14Expiration date for stock options

Keywords

Form 4, P10, Inc., Stock Options, Restricted Stock Units, Insider Trading, Executive Compensation, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.